Table 5 Compared analyses for jaundiced patients with and without long survival (n = 54)

Male gender

2

28

0.221

Mean age

57.43 ± 10.96

62.14 ± 10.06

0.288

Associated gallbladder stone

4

21

0.692

Preoperative biliary drainage

2

31

0.096

Tumor location

0.660

  Neck

6 (85.7%)

32 (68.1%)

  Body/fundus

1 (14.3%)

15 (31.9%)

Postoperative hospital stay

12.29 ± 3.82

19.21 ± 13.56

0.188

Bilirubin level at presentation

183.06 ± 103.79

251.93 ± 133.50

0.149

Intraoperative bleeding (ml)

785.71 ± 371.61

637.23 ± 553.49

0.380

Intraoperative blood infusion

6 (85.7%)

17 (36.2%)

0.034

Operative time (min)

320.00 ± 80.83

292.45 ± 76.57

0.423

Combined resection of adjacent organs

1 (14.3%)

8 (17%)

0.670

Hepatic invasion

4 (57.1%)

25 (53.2%)

0.585

pT (TNM)

0.010

  pT3

5 (71.4%)

9 (19.1%)

  pT4

2 (28.6%)

38 (80.9%)

Lymph node metastasis

5 (71.4%)

34 (72.3%)

0.637

Histologic type

0.576

  Well + moderately differentiated

7 (100%)

40 (85.1%)

  Poorly differentiated

0 (0%)

7 (14.9%)

Extent of liver resection

0.219

  Major hepatectomy (> 3 segments)

0 (0%)

4 (8.5%)

  Anatomical segments IV–V

1 (14.3%)

19 (40.4%)

  Gallbladder bed

6 (85.7%)

24 (51.1%)

CRAO

0.670

  Yes

1 (14.3%)

8 (17.0%)

  No

6 (85.7%)

3 (83.0%)

Combined portal vein/hepatic artery resection

0 (0%)

5 (10.6%)

0.485

Incidence of incidental gallbladder cancer (IGC)

1 (14.3%)

1 (2.13%_)

0.2445